Clinical Trial Update: Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer [Phase 2]

View source ↗

Summary

The Phase 2 clinical trial evaluating ALPPS or portal vein occlusion for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: WITHDRAWN